If they sell the patents they may as well sell the company .. which would be fine by me at the right price .. north of probably $5 before anything is approved .. however licensing the patents holds billions in recurring rev's .. I'll take that too.
It would be nice if they sold. If I'm being honest, I don't want to wait 2-3 years for a big payday. I think a buyout in 2021 would be best case scenario for everyone. Here's hoping some company steps to the plate once animal testing is complete.
Market Data 
Markets 
